1. An Updated and Comprehensive Meta-Analysis of Association Between Seven Hot Loci Polymorphisms from Eight GWAS and Glioma Risk
   Qiang Wu et al, 2016, Molecular Neurobiology CrossRef
2. Long Noncoding RNA miR210HG as a Potential Biomarker for the Diagnosis of Glioma
   Weijie Min et al, 2016, PLOS ONE CrossRef
3. Down regulation of human telomerase reverse transcriptase (hTERT) expression by BIBR1532 in human glioblastoma LN18 cells
   C. Lavanya et al, 2018, Cytotechnology CrossRef
4. Integrin α10, a Novel Therapeutic Target in Glioblastoma, Regulates Cell Migration, Proliferation, and Survival
   Matilda Munksgaard Thorén et al, 2019, Cancers CrossRef
5. The Paracrine Effect of Hypoxic and Normoxic Cancer Secretion on the Proliferation of Brain Endothelial Cells (bEnd.3)
   Mariam Rado et al, 2022, Cells CrossRef
6. A Promising Way to Overcome Temozolomide Resistance through Inhibition of Protein Neddylation in Glioblastoma Cell Lines
   Barbara Brandt et al, 2023, International Journal of Molecular Sciences CrossRef
7. Inhibition of growth of U87MG human glioblastoma cells by Usnea longissima Ach.
   BUGRAHAN EMSEN et al, 2019, Anais da Academia Brasileira de Ciências CrossRef
8. Tumour-specific triple-regulated oncolytic herpes virus to target glioma
   Zahid M. Delwar et al, 2016, Oncotarget CrossRef
9. Glioblastoma therapy: State of the field and future prospects
   Nadia Allahyarzadeh Khiabani et al, 2024, Life Sciences CrossRef
10. Гліобластома: огляд літератури
    Dipak Chaulagain et al, 2023, INTERNATIONAL NEUROLOGICAL JOURNAL CrossRef
11. Evaluation on the diagnostic and prognostic values of long non-coding RNA BLACAT1 in common types of human cancer
    Xiaoli Chen et al, 2017, Molecular Cancer CrossRef
12. Alpha2beta1 Integrin Polymorphism in Diffuse Astrocytoma Patients
    Silvia A. Teixeira et al, 2022, Frontiers in Oncology CrossRef
13. Leptomeningeal and intramedullary metastases of glioblastoma multiforme in a patient reoperated during adjuvant radiochemotherapy
    Josip Joachim Grah et al, 2013, World Journal of Surgical Oncology CrossRef
14. Esculin and its oligomer fractions inhibit adhesion and migration of U87 glioblastoma cells and in vitro angiogenesis
    Imen Mokdad-Bzeouich et al, 2016, Tumor Biology CrossRef
15. Temozolomide with or without Radiotherapy in Patients with Newly Diagnosed Glioblastoma Multiforme: A Meta-Analysis
    Enshan Feng et al, 2017, European Neurology CrossRef
16. A novel amplification-based approach to enable gene expression profiling from small clinical tumor specimens
    Haya Sarras et al, 2016, Journal of Neuro-Oncology CrossRef
17. Alkaloids of fascaplysin are effective conventional chemotherapeutic drugs, inhibiting the proliferation of C6 glioma cells and causing their death in vitro
    Igor Bryukhovetskiy et al, 2017, Oncology Letters CrossRef
18. The Current State of Potential Therapeutic Modalities for Glioblastoma Multiforme: A Clinical Review
    Elmira Mohtashami et al, 2020, Current Drug Metabolism CrossRef
19. Downregulation of Pygopus 2 inhibits vascular mimicry in glioma U251 cells by suppressing the canonical Wnt signaling pathway
    HAIDONG WANG et al, 2016, Oncology Letters CrossRef
20. In vitro cytotoxicity of cardamom oil, lemon oil, and jasmine oil on human skin, gastric, and brain cancer cell line
    Chetan Manjunath et al, 2021, Journal of Cancer Research and Therapeutics CrossRef
21. PPFIBP1 induces glioma cell migration and invasion through FAK/Src/JNK signaling pathway
    Caihua Dong et al, 2021, Cell Death & Disease CrossRef
22. Assessment of the proliferation status of glioblastoma cell and tumour tissue after nanoplatinum treatment
    Marta Kutwin et al, 2017, PLOS ONE CrossRef
23. Unilateral malignant optic glioma following glioblastoma multiforme in the young: a case report and literature review
    Chia-Ying Lin et al, 2017, BMC Ophthalmology CrossRef
24. In vitroantitumor activities of the lichen compounds olivetoric, physodic and psoromic acid in rat neuron and glioblastoma cells
    Bugrahan Emsen et al, 2016, Pharmaceutical Biology CrossRef
25. Longevity‐Related Gene Transcriptomic Signature in Glioblastoma Multiforme
    Manal S. Fawzy et al, 2018, Oxidative Medicine and Cellular Longevity CrossRef
26. ERBB signaling in CTCs of ovarian cancer and glioblastoma
    Anjali Geethadevi et al, 2017, Genes & Cancer CrossRef
27. Knockdown of Tousled‑like kinase 1 inhibits survival of glioblastoma multiforme cells
    Kamariah Ibrahim et al, 2020, International Journal of Molecular Medicine CrossRef
28. The PHLDB1 rs498872 (11q23.3) polymorphism and glioma risk: A meta-analysis
    Xingchun Gao et al, 2015, Asia-Pacific Journal of Clinical Oncology CrossRef
29. Multivariate signaling regulation by SHP2 differentially controls proliferation and therapeutic response in glioma cells
    Christopher M. Furcht et al, 2014, Journal of Cell Science CrossRef
30. The immunohistochemical expression of c-Met is an independent predictor of survival in patients with glioblastoma multiforme
    O. F. Olmez et al, 2014, Clinical and Translational Oncology CrossRef
31. Temozolomide and Radiotherapy for Newly Diagnosed Glioblastoma Multiforme: A Systematic Review
    Li-Juan Yang et al, 2014, Cancer Investigation CrossRef
32. FoxG1 facilitates proliferation and inhibits differentiation by downregulating FoxO/Smad signaling in glioblastoma
    Lei Wang et al, 2018, Biochemical and Biophysical Research Communications CrossRef
33. Empirical Studies on Effect of Low-Level Laser Treatment on Glioblastoma Multiforme in Combination with Ag-PMMA-PAA Nanoparticles: Paired Red Region Optical-Property Treatment Platform
    Rohini Atluri et al, 2022, Applied Nano CrossRef
34. Convection-enhanced delivery of cetuximab conjugated iron-oxide nanoparticles for treatment of spontaneous canine intracranial gliomas
    A. Courtenay Freeman et al, 2018, Journal of Neuro-Oncology CrossRef
35. Transcriptional modulation of calcium‐permeable AMPA receptor subunits in glioblastoma by MEK–ERK1/2 inhibitors and their role in invasion
    Palaniswamy Ramaswamy et al, 2020, Cell Biology International CrossRef
36. Celecoxib Suppresses NF-κB p65 (RelA) and TNFα Expression Signaling in Glioblastoma
    Hina Ahsan et al, 2023, Journal of Clinical Medicine CrossRef
37. A Ploidy Increase Promotes Sensitivity of Glioma Stem Cells to Aurora Kinases Inhibition
    Chiara Cilibrasi et al, 2019, Journal of Oncology CrossRef
38. Pre-Operative Peritumoral Edema and Survival Rate in Glioblastoma Multiforme
    Shui-Yuan Liu et al, 2013, Oncology Research and Treatment CrossRef
39. The Impact of Epigenetic Methylation on Gliomagenesis: An Understanding and Therapeutic Approaches
    Kholoud Arafa et al, 2024, CrossRef
40. Investigating the use of Raman and immersion Raman spectroscopy for spectral histopathology of metastatic brain cancer and primary sites of origin
    Leanne M. Fullwood et al, 2014, Anal. Methods CrossRef
41. Early Differentiating Mouse Astroglial Progenitors Share Common Protein Signatures with GL261 Glioma Cells
    null null et al, 2016, Journal of Stem Celll and Regenerative Biology CrossRef
42. Application of an assay Cascade methodology for a deep preclinical characterization of polymeric nanoparticles as a treatment for gliomas
    Cristina Fornaguera et al, 2018, Drug Delivery CrossRef
43. The CXCL12/CXCR4 axis confers temozolomide resistance to human glioblastoma cells via up-regulation of FOXM1
    Shengwen Wang et al, 2020, Journal of the Neurological Sciences CrossRef
44. Degradation of Mitochondria and Oxidative Stress as the Main Mechanism of Toxicity of Pristine Graphene on U87 Glioblastoma Cells and Tumors and HS-5 Cells
    Sławomir Jaworski et al, 2019, International Journal of Molecular Sciences CrossRef
45. Biological Microniches Characterizing Pathological Lesions
    Ismail M. Meraz et al, 2013, Nanomedicine CrossRef
46. IGFBP2 Is a Potential Master Regulator Driving the Dysregulated Gene Network Responsible for Short Survival in Glioblastoma Multiforme
    Manasa Kalya et al, 2021, Frontiers in Genetics CrossRef
47. SAE1 promotes human glioma progression through activating AKT SUMOylation-mediated signaling pathways
    Yanfang Yang et al, 2019, Cell Communication and Signaling CrossRef
48. Therapeutics and Research Related to Glioblastoma: Advancements and Future Targets
    Vishal Chavda et al, 2020, Current Drug Metabolism CrossRef
49. Polymeric and lipid-based drug delivery systems for treatment of glioblastoma multiforme
    Ramesh Duwa et al, 2019, Journal of Industrial and Engineering Chemistry CrossRef
50. Clinical cases in neuro-oncology
    Kostas Konstantopoulos et al, 2023, Neuroimaging in Neurogenic Communication Disorders CrossRef
51. In Silico and Glioblastoma Cell Line Evaluation of Thioflavin-Derived Zinc Nanoparticles Targeting Beclin Protein
    Parineeta Dandagi et al, 2024, Cureus CrossRef
52. Peritumoral edema on magnetic resonance imaging predicts a poor clinical outcome in malignant glioma
    CHEN-XING WU et al, 2015, Oncology Letters CrossRef
53. Maximizing Local Access to Therapeutic Deliveries in Glioblastoma. Part III: Irreversible Electroporation and High-Frequency Irreversible Electroporation for the Eradication of Glioblastoma
    null null et al, 2017, Glioblastoma CrossRef
54. p53 supplementation as a targeted cancer gene therapy for glioblastoma
    Uday Kumar Sukumar et al, 2021, Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies CrossRef
55. A Repurposed Drug for Brain Cancer: Enhanced Atovaquone Amorphous Solid Dispersion by Combining a Spontaneously Emulsifying Component with a Polymer Carrier
    Hiroyuki Takabe et al, 2018, Pharmaceutics CrossRef
56. Application of Neurokinin-1 Receptor in Targeted Strategies for Glioma Treatment. Part I: Synthesis and Evaluation of Substance P Fragments Labeled with 99mTc and 177Lu as Potential Receptor Radiopharmaceuticals
    Agnieszka Majkowska-Pilip et al, 2018, Molecules CrossRef
57. Advancements in nanotheranostics for glioma therapy
    Liza Sahoo et al, 2024, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
58. Identification of hub genes and regulatory factors of glioblastoma multiforme subgroups by RNA-seq data analysis
    Yanan Li et al, 2016, International Journal of Molecular Medicine CrossRef
59. The Effect of Normoxic and Hypoxic U-87 Glioblastoma Paracrine Secretion on the Modulation of Brain Endothelial Cells
    Mariam Rado et al, 2022, Cells CrossRef
60. AshwaMAX and Withaferin A inhibits gliomas in cellular and murine orthotopic models
    Edwin Chang et al, 2016, Journal of Neuro-Oncology CrossRef
61. Investigating the impact of headaches on the quality of life of patients with glioblastoma multiforme: a qualitative study
    Samuel Robert Bennett et al, 2016, BMJ Open CrossRef
62. Nanotechnology and Nanocarrier-Based Drug Delivery as the Potential Therapeutic Strategy for Glioblastoma Multiforme: An Update
    Jen-Fu Hsu et al, 2021, Cancers CrossRef
63. Symptom management in adult brain tumours: A literature review
    Rong Zhang et al, 2023, Nursing Open CrossRef
64. Study of Gene Expression in Glioblastoma Hypoxic Model
    Deeksha Sharma et al, 2023, Research Journal of Pharmacy and Technology CrossRef
65. Combined inhibition of STAT and Notch signalling effectively suppresses tumourigenesis by inducing apoptosis and inhibiting proliferation, migration and invasion in glioblastoma cells
    Israt Jahan Tulip et al, 2021, Animal Cells and Systems CrossRef
66. Enhanced proteasomal activity is essential for long term survival and recurrence of innately radiation resistant residual glioblastoma cells
    Jacinth Rajendra et al, 2018, Oncotarget CrossRef
67. PEGylated solid lipid nanoparticles for brain delivery of lipophilic kiteplatin Pt(IV) prodrugs: An in vitro study
    Ilaria Arduino et al, 2020, International Journal of Pharmaceutics CrossRef